Brain natriuretic peptide in the left ventricle hypertrophy;Peptyd natriuretyczny typu B w przeroście mieśnia lewej komory serca

Folia Cardiologica

Volumn 10, Issue 4, 2003, Pages 431-436

  Grabowski, Maciej ^a   Orłowska Baranowska, Ewa ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARDIOTROPHIN 1; NATRIURETIC PEPTIDE TYPE C;

ARTICLE; DISEASE SEVERITY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; NORTHERN BLOTTING; PATHOGENESIS; PROTEIN DETERMINATION;

EID: 0141426557     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wei C., Heublein D., Perrella M. i wsp. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004-1009.
2. Stein B., Levin R. Natriuretic peptides: physiology, therapeutic potential and risk stratification in ischemic heart disease. Am. Heart J. 1998; 135: 914-923.
3. Cowie M. BNP: soon to become a routine measure in the care of patients with heart failure. Heart 2000; 83: 617-618.
4. Hunt P., Yandle T., Nicholls M. i wsp. The aminoterminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem. Biophys. Res. Commun. 1995; 214: 1175-1183.
5. Saito Y., Nakao K., Suga S. i wsp. Brain natriuretic peptide is a novel cardiac hormone. Biochem. Biophys. Res. Commun. 1989; 158: 360-368.
6. Itoh H., Nakao K., Kambayashi Y. i wsp. Occurence of a novel cardiac natriuretic peptide in rats. Biophys. Res. Commun. 1989; 161: 732-739.
7. Kambayashi Y., Nakao K., Mykoyama M. i wsp. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett. 1990; 259: 341-345.
8. Steinhelper M.E. Structure, expression and genomic mapping of the mouse natriuretic type B gene. Circulation Research 1993; 72: 984.
9. Cheung B., Kumana C. Natriuretic peptides-relevance in cardiac disease. JAMA 1998; 280: 1983-1984.
10. Heublein D. Clavell A., Stingo A. i wsp. C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides 1992; 13: 1017-1019.
11. Stingo A., Clavell A., Heublein D. i wsp. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol. 1992; 263: H1318-H1321.
12. Suga S., Itoh H., Komatsu Y. i wsp. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of "vascular natriurtic peptide system". J. Clin. Invest. 1992; 90: 1145-1149.
13. Komatsu Y., Nakao K., Suga S. i wsp. C-type natriuretic peptide in rats and humans. Endocrinology 1991; 129: 1104-1106.
14. Koller K., Lowe D., Bennet G. i wsp. Selective activation of the B-natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991; 252: 120-123.
15. Mallet Ch., Nicaud V., Arveiler D. i wsp. Brain natriuretic peptide (BNP) gene polymorphism in ECTIM study (http:II gene canvas.idf.inserm.fr).
16. Mizuno Y., Yoshimura M., Harada E. i wsp. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomypathy or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 2000; 86: 1036-1040.
17. Wallen T., Landahl S., Hedner T. i wsp. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997; 77: 264-267.
18. Gackowski A., Isnard R., Piwowarska W. i wsp. Peptyd natriuretyczny typu B. Nowa metoda w diagnostyce niewydolności serca. Kardiol. Pol. 2002; 56: 644-648.
19. Yasue H., Yoshimura M., Sumida H. i wsp. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subject and patients with heart failure. Circulation 1994; 90: 195-203.
20. Hosoda K., Nakao K., Mukoyama M. i wsp. Expression of brain natriuretic peptide gene in human heart. Hypertension 1991; 17: 1152-1156.
21. Maeda K., Takayoshi T., Wada A. i wsp. Plasma brain natriuretic peptide as a biochemical marker of high level ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am. Heart J. 1998; 135: 825-832.
22. Cheng V., Kazanagra. R., Garcia A. i wsp. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted for decompensated heart failure. A pilot study. J. Am. Coll. Cardiol. 2001; 37: 386-391.
23. McDonagh T., Robb S., Murdoch D. i wsp. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
24. Cowie M., Struthers A., Wood D. i wsp. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1349-1352.
25. Mukoyama M., Nakao K., Saito Y. i wsp. Increased human brain natriuretic peptide in congestive heart failure. N. Engl. J. Med. 1990; 323: 757-758.
26. Mukoyama M., Nakao K., Obata K. i wsp. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem. Biophys. Res. Commun. 1991; 180: 431-436.
27. Kohno M., Horio T., Yokokawa K. i wsp. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am. J. Med. 1992; 92: 29-34.
28. Ikeda T., Matsuda K., Itoh H. i wsp. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am. Heart J. 1997; 133: 307-314.
29. Grossman W., Jones D., McLaurin L. i wsp. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 1975; 56: 56-64.
30. Reichek N., Wilson J., Sutton M. i wsp. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982; 65: 99-108.
31. Graham T., Frankiln R., Wyse R. i wsp. Left ventricular wall stress and contractile function in childhood: normal values and comparison of Fontan repair versus palliation only in patients with tricuspid atresia. Circulation 1986; 74 (supl. I): I61-I69.
32. Brown L., Nunez D., Wilkins M. i wsp. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J. Clin. Invest. 1993; 92: 2702--2712.
33. Qi W., Mathisen P., Kjekshus J. i wsp. Natriuretic peptides in patients with aortic stenosis. Am. Heart J. 2001; 142: 725-732.
34. Prasad N., Bridges A., Lang C. i wsp. Brain natriuretic peptide concentrations in patients with aortic stenosis. Am. Heart J. 1997; 133: 477-479.
35. Fujinaga K., Onoda K., Kanemitsu S. i wsp. Study of plasma levels of brain natriuretic peptide (BNP) in the late phase after aortic valve replacement. Jpn. J. Cardiocasc. Surg. 2000; 29: 320-325.
36. Talwar S., Downie P., Squire I. i wsp. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur. J. Heart Fail. 2001; 3: 15-49.
37. Pennica D., King K., Shaw K. i wsp. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 1995; 92: 1142-1146.
38. Masahiro I., Yoshihiko S., Yoshihiro M. i wsp. A heart--specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J. Hypertens. 1999; 17: 807-816.
39. Pan J., Fukuda K., Saito M. i wsp. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ. Res. 1999; 84: 1127-1136.
40. Mallet Ch., Mc Donagh T., Dargie H. i wsp. Brain natriuretic peptide (BNP) gene polymorphism in the GLAECO and GLAOLD Studies (http:II genecanvas.idf.inserm.fr).